Important publications

Publikační okénko obsahuje výběr z impaktovaných publikací fakulty od roku 2006 do současnosti. Chceme tak upozornit akademickou obec na významnější publikace, které vyšly u nás na fakultě, a blíže představit vědecké úspěchy jednotlivých pracovišť. Publikace vybíráme na základě několika kritérií, zejména IF a podílu autorů z 2. LF UK.

Standardization of Workflow and Flow Cytometry Panels for Quantitative Expression Profiling of Surface Antigens on Blood Leukocyte Subsets: An HCDM CDMaps Initiative

14. 3. 2023

Daniela Kužílková, Joan Puñet-Ortiz, Pei M. Aui, Javier Fernández, Karel Fišer, Pablo Enge, Menno C. van Zelm and Tomáš Kalina. Frontiers in Immunology. 2022 February 11. IF: 7,561. doi

Immunoprofiling of Monocytes in STAT1 Gain-Of-Function Chronic Mucocutaneous Candidiasis

14. 3. 2023

Marketa Bloomfield, Irena Zentsova, Tomas Milota, Anna Sediva and Zuzana Parackova. Frontiers in Immunology. 2022 September 12. IF: 8,786. doi

Distinct CD8 T Cell Populations with Differential Exhaustion Profiles Associate with Secondary Complications in Common Variable Immunodeficiency

9. 3. 2023

Adam Klocperk, David Friedmann, Alexandra Emilia Schlaak, Susanne Unger, Zuzana Parackova, Sigune Goldacker, Anna Sediva, Bertram Bengsch & Klaus Warnatz. Journal of Clinical Immunology. 2022 May 19. IF: 8,542. doi.

Immunogenicity and Safety of the Booster bnt162b2 Vaccine in Patients With Axial Spondyloarthritis Treated With Biological Disease-Modifying Drugs

21. 2. 2023

Jitka Smetanova, Tomas Milota, Michal Rataj, Jana Hurnakova, Hana Zelena, Anna Sediva and Rudolf Horvath. Frontiers in Immunology. 2022 September 23. IF: 8,786
doi.

Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety

21. 2. 2023

Monika Svorcova, Rene Novysedlak, Robert Lischke, Jiri Vachtenheim Jr and Zuzana Strizova. Frontiers in Immunology. 2022 June 1. IF: 8,786. doi.

doc. PharmDr. Jitka Palich Fučíková, Ph.D.

An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors

14. 2. 2023

Jitka Fucikova, Michal Hensler, Lenka Kasikova, Tereza Lanickova, Josef Pasulka, Jana Rakova, Jana Drozenova, Tessa Fredriksen, Marek Hraska, Tereza Hrnciarova, Klara Sochorova, Daniela Rozkova, Ludek Sojka, Pavel Dundr, Jan Laco, Tomas Brtnicky, Ivan Praznovec, Michael J Halaska, Lukas Rob, Ales Ryska, An Coosemans, Ignace Vergote, David Cibula, Jirina Bartunkova, Jérôme Galon, Lorenzo Galluzzi, Radek Spisek. Clinical Cancer Research. 2022 July 15. IF: 13,801
doi.org/10.1158/1078-0432.CCR-21-4413.

Přepínač jazyka

Přepínač jazyka

Important publications

Standardization of Workflow and Flow Cytometry Panels for Quantitative Expression Profiling of Surface Antigens on Blood Leukocyte Subsets: An HCDM CDMaps Initiative

Immunoprofiling of Monocytes in STAT1 Gain-Of-Function Chronic Mucocutaneous Candidiasis

Distinct CD8 T Cell Populations with Differential Exhaustion Profiles Associate with Secondary Complications in Common Variable Immunodeficiency

Immunogenicity and Safety of the Booster bnt162b2 Vaccine in Patients With Axial Spondyloarthritis Treated With Biological Disease-Modifying Drugs

Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety

An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors

Drobečková navigace

Important publications

Standardization of Workflow and Flow Cytometry Panels for Quantitative Expression Profiling of Surface Antigens on Blood Leukocyte Subsets: An HCDM CDMaps Initiative

Immunoprofiling of Monocytes in STAT1 Gain-Of-Function Chronic Mucocutaneous Candidiasis

Distinct CD8 T Cell Populations with Differential Exhaustion Profiles Associate with Secondary Complications in Common Variable Immunodeficiency

Immunogenicity and Safety of the Booster bnt162b2 Vaccine in Patients With Axial Spondyloarthritis Treated With Biological Disease-Modifying Drugs

Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety

An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors